Wave Life Sciences WVE
NASDAQ WVE
$4.82 +0.12 (+2.53%)
As of: Sep 4, 2026 · 1:41 PM EDT

Wave Life Sciences (WVE) Interest & Investment Income (2015 - 2026)

Wave Life Sciences' (WVE) quarterly Interest & Investment Income came in at $4.7 million in Q2 2026, up 99.07% YoY from $2.4 million in Q2 2025, and down 10.75% on a QoQ basis from $5.3 million in Q1 2026.

Analysis

Wave Life Sciences (WVE) Interest & Investment Income (2015 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 7 years of Interest & Investment Income data on file, last reported at $4.7 million in Q2 2026.

  • Quarterly Interest & Investment Income rose 99.07% year-over-year to $4.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.2 million (up 41.37% YoY) and the FY2025 annual result came in at $10.5 million, up 3.1% from the prior year.
  • Interest & Investment Income slipped to $4.7 million in Q2 2026, from $5.3 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q1 2026 to a low of $26000.0 in Q1 2022.
  • A 5-year average of $2.2 million and a median of $2.1 million in 2024 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income surged 16400.0% — and 2025, when it fell 18.3%.
  • Tracing WVE's Interest & Investment Income over 5 years: stood at $825000.0 in 2022, then jumped by 123.52% to $1.8 million in 2023, then soared by 102.71% to $3.7 million in 2024, then decreased by 18.3% to $3.1 million in 2025, then jumped by 54.62% to $4.7 million in 2026.
  • The last three Interest & Investment Income figures came in at $4.7 million (Q2 2026), $5.3 million (Q1 2026), and $3.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 Wave Life Sciences 983.14 Mn 615.13 Mn - 4.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.72 Mn
Mar 31, 2026 5.29 Mn
Dec 31, 2025 3.05 Mn
Sep 30, 2025 2.18 Mn
Jun 30, 2025 2.37 Mn
Mar 31, 2025 2.88 Mn
Dec 31, 2024 3.74 Mn
Sep 30, 2024 1.80 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 2.54 Mn
Dec 31, 2023 1.84 Mn
Sep 30, 2023 1.96 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 1.87 Mn
Dec 31, 2022 825,000.00
Sep 30, 2022 596,000.00
Jun 30, 2022 124,000.00
Mar 31, 2022 26,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 6,000.00